ICD-10-CM D61.82 is the diagnosis code for Myelophthisis. This code falls under the section "Aplastic and other anemias and other bone marrow failure syndromes" within Chapter 3 — Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions should never be coded at the same time as D61.82. They are mutually exclusive:
Understanding where D61.82 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, D61.82 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
D61.82 is the ICD-10-CM diagnosis code for "Myelophthisis". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of D61.82 is D61.8 ("Other specified aplastic anemias and other bone marrow failure syndromes"). D61.82 provides a more specific classification within this category.
D61.82 is located in Section D60-D64 — "Aplastic and other anemias and other bone marrow failure syndromes" within Chapter 3 of the ICD-10-CM Tabular List.
Use D61.82 when the patients documented diagnosis matches "Myelophthisis" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Myelophthisis is D61.82.
Yes, D61.82 can be used as a primary diagnosis code since it is billable and specific.
D61.82 is in Chapter 3 of the ICD-10-CM Tabular List.
Type 1 Excludes for D61.82 include: idiopathic myelofibrosis (D47.1); myelofibrosis NOS (D75.81); myelofibrosis with myeloid metaplasia (D47.4) and more.
Yes, D61.82 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.